Dean Johnson featured on Thomson Reuters’ Highly Cited Researchers List

Published: October 6th, 2015

Category: News, Pharmacotherapy and Translational Research News

Thomson Reuters has named Julie Johnson, Pharm.D., dean and distinguished professor at the College of Pharmacy, as one of its Highly Cited Researchers of 2015. The honor recognizes some of the world’s most influential scientific minds and is earned by being among the top one percent most cited researchers in a subject field. About 3,000 researchers globally earned the distinction by writing the greatest number of reports officially designated by Essential Science Indicators as Highly Cited Papers.

Thomson Reuters featured Johnson in the pharmacology and toxicology category. She is recognized internationally as one of the leading researchers in the field of pharmacogenomics and has published over 230 peer-reviewed publications and 120 peer-reviewed abstracts. She has obtained nearly $40 million in funding as a principal investigator over her career and directs UF’s Personalized Medicine Program.

Also listed in the same category is Yuichi Sugiyama, Ph.D., a 2015 honorary degree recipient of the University of Florida and friend of the College of Pharmacy. Sugiyama is one of the world’s top pharmaceutical scientists and the world leader in pharmacokinetics and molecular biology of membrane transporters, drug metabolism and pharmacology. A former professor and chair of the department of molecular pharmacokinetics at the University of Tokyo, he has published more than 600 original articles, reviews and chapters and given invited lectures at 200 international conferences. He has had an important and long-lasting effect on research and education at UF, by partnering with College of Pharmacy leaders to support the biannual Retrometabolism and Global Gators meetings.